Diabetics with advancing age accompanying symptoms like high blood pressure, excessive waist fat, and cholesterol imbalance induce poor metabolic control associated with microvascular and microvascular complications. CVD (Cardiovascular disease) threat develops with a mild increase in fasting blood glucose level before it touches to be diagnosed as diabetic.
Obesity: Visceral fat-associated obesity provokes low-grade inflammation in diabetics and raises CVD danger.
Epigenetics: A complex mechanism of connection between histone methylation and DNA causing obesity encourages diabetes-influenced CVD risk.
Inflammation: Overexpression of cytokines caused by adipose tissue and activated macrophages establishes subclinical inflammation in obese diabetics with insulin resistance. Atherosclerosis and CVD develop when these cytokines join chronic inflammatory processes of vessel walls and induce lipid accumulation.
Hyperglycemia: Acute hyperglycemia and glucose fluctuations decrease insulin sensitivity and increase T-cell loss, mitochondrial superoxide production, and endoplasmic reticulum stress by causing glucotoxicity, endothelium-dependent vasodilation, reduced myocardial perfusion, and inflammatory responses.
Hypertension: High blood pressure can be observed before finding hyperglycemia.
Hypertension: Along with diabetes initiates rapid oxidative stress-induced vascular dysfunction and injury.
Dyslipidemia: Diabetics with dyslipidemia show a thermogenic profile consisting of enhanced very low-density lipoprotein cholesterol, triglycerides, and small & dense low-density lipoprotein cholesterol levels & reduced high-density lipoprotein cholesterol levels.
Oxidative stress: Hexosamine and aldose reductase pathways get activated due to increased intracellular glucose concentrations. There is an oxidative load on mitochondria, increased production of reactive nitrogen species, and inflammatory cytokines. Also, there is a formation of advanced end products and the activation of protein kinase. Cumulatively these changes cause an increment in oxidative stress.
Endothelial dysfunction: In diabetics, endothelium-dependent vasodilation disrupts reduced nitric oxide (NO) production from endothelial cells causing increased oxidative stress. Altogether in diabetics, imbalanced NO metabolism leads to microvascular complications.
Cardiovascular autonomic neuropathy: Autonomic imbalance (ANS), inflammation, and CVD erupt in diabetics due to elevated inflammatory markers, increased sympathetic activity, and dysregulation of the autonomic nervous system. ANS destruction causes arterial stiffness, left ventricular hypertrophy, ventricular systolic dysfunction, and modulation of the sinus node, ventricular, and blood vessels.
● Maintain good glycemic control by providing early hyperglycemia treatment associated with metabolic memory protective effects
● Halt obesity by decreasing excessive visceral fat
● Manage dyslipidemia and aggressive atherosclerosis danger
● Control hypertension co-occurrence and cardiovascular morbidity and mortality
● Lower oxidative stress and slow down CVD progression
● Manage epigenetics influence increased body weight and fat level
● Stop inflammatory cascade which promotes cardiovascular imbalance
● Disrupt endothelial dysfunction
● Avoid cardiovascular Autonomic Neuropathy (CAN) manifestation
● Include mandatory screening schedule
● Follow a positive dedicated healthy heart care lifestyle
The key to reducing the burden of diabetes on the cardiovascular system is to identify the optimal time to introduce a suitable combination of personalized approaches & right disease-modifying agents.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation